Chimerix is now part of Jazz Pharmaceuticals. Learn more at www.jazzpharma.com

onc201

Dopamine receptor D5 is a modulator of tumor response to dopamine receptor D2 antagonism

Clin Cancer Res. 2019 PMID: 30559168

View Publication